Anemia Management in the Era of Triple Combination Therapy for Chronic HCV

Boceprevir or telaprevir plus ribavirin (RBV) and pegylated interferon-α (pegIFN-α) is the new standard-of-care therapy for patients who are chronically infected with genotype 1 hepatitis C virus (HCV). The addition of these protease inhibitors to the RBV/pegIFN-α combination regimen has significant...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Jacobson, Ira M., Kowdley, Kris V., Kwo, Paul Y.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Millennium Medical Publishing 2012
Ämnen:
CMExpress Opportunity
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533206/
https://ncbi.nlm.nih.gov/pubmed/23293572
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk